Gilead Sciences, Inc.GILDNASDAQ
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank79
3Y CAGR+7.2%
5Y CAGR+7.6%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
+7.2%/yr
vs +3.4%/yr prior
5Y CAGR
+7.6%/yr
Consistent
Acceleration
+3.8pp
Accelerating
Percentile
P79
Within normal range
vs 5Y Ago
1.4x
Solid growth
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 5.76 | +25.7% |
| 2024 | 4.59 | +3.7% |
| 2023 | 4.43 | -5.4% |
| 2022 | 4.68 | +13.4% |
| 2021 | 4.12 | +3.2% |
| 2020 | 4.00 | -6.1% |
| 2019 | 4.25 | +3.9% |
| 2018 | 4.09 | -10.6% |
| 2017 | 4.58 | +22.1% |
| 2016 | 3.75 | - |